Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Clinical trial NCT00623766 · COMPLETED
Trial details
- NCT number
- NCT00623766
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-09-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.